SEATTLE, Oct. 26, 2012 /PRNewswire/ -- On Tuesday, October 30, 2012, at 8:30 a.m. Eastern/1:30 p.m. Central European/5:30 a.m. Pacific, members of Cell Therapeutics, Inc.'s (CTI) (NASDAQ and MTA: CTIC) management team will host a conference call to discuss the Company's 2012 third quarter achievements and financial results.
Conference Call Numbers
Tuesday, October 30th
8:30 a.m. Eastern/1:30 p.m. Central European/5:30 a.m. Pacific Time
1-877-941-2333 (US Participants)
1-480-629-9773 (International)
Call-back numbers for post-listening available at 11:30 a.m. Eastern:
1- 800-406-7325 (US Participants)
1- 303-590-3030 (International)
Passcode: 4572038 #
Live audio webcast at www.celltherapeutics.com will be archived for post listening approximately two hours after call ends.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.
Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert
| Media Contact: | Investors Contact: |
| Dan Eramian | Ed Bell |
| T: 206.272.4343 | T: 206.272.4345 |
| C: 206.854.1200 | |
| F: 206.272.4434 | |
SOURCE Cell Therapeutics, Inc.